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Aim: To investigate the informed consent experiences of women with human
immunodeficiency virus (HIV) and childhood trauma involved in a neurocognitive and
neuroimaging study. Background: There is no previous research on the consent
process for people with both HIV and childhood trauma, conditions that are syndemic
in South Africa. Research on the consent process for each individual condition has
shown that individuals with either of these conditions may be vulnerable research
participants. This study aimed to investigate the opinions of the women involved in
order to refine future consent processes and ensure that they are appropriate for this
population. Methods: A qualitative semi-structured interview was conducted with
women from Khayelitsha township in South Africa involved in a cohort study on
neurocognitive and neuroimaging outcomes in HIV and childhood trauma, who
agreed to participate in an interview immediately following their final study appoint-
ment. Findings: Aspects most frequently commented upon by participants during the
interview were community recruitment, incentives for participation, quality of infor-
mation provided, and misunderstandings and unexpected events. The overarching
finding was that of therapeutic misconception; participants expected, and highlighted
as incentives for participation, health benefits that were not part of the study. A
minority of participants reported discomfort from questions concerning their trau-
matic experiences. Despite this, the consent process was well received and there was
good understanding of confidentiality issues and the voluntariness of participation.
Conclusion: Full disclosure of true benefits from participation must be emphasised
throughout the recruitment process. This is particularly important for participants with
HIV who appear to participate because of perceived health incentives. Providing prior
notification that questions about traumatic experiences will be asked may improve the
experiences of participants. A generic but thoroughly conducted consent process is
suitable in this population.
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Introduction
Human immunodeficiency virus (HIV) is a large
burden for South Africa with 17.3% of the
population infected in 2011 (Shisana et al., 2009).
This burden has prompted much research, the
advancement of new therapeutics, and investiga-
tion of co-existing factors that contribute to
poorer outcomes. One co-morbidity currently
under investigation is childhood trauma (CHT).
CHT is defined as ‘a repeated pattern of damaging
interactions between parent(s) [or other significant
adults] and child that becomes typical of the rela-
tionship’ (Dunsmore, 2013). Such traumas lie at the
root of many psychiatric disorders (Murray, 2008)
and, in HIV, may compound neurocognitive deficits
and dementia resulting from HIV alone.
The context for this research impetus is a
country still recovering from the turmoil of
apartheid, abolished in 1994 (Choksi et al., 1995;
King, 2010), where many black South Africans
remain trapped in a vicious circle of poor edu-
cation and poverty and have become confined by
means to informal settlements (Myer et al., 2004).
This situation coupled with a previously poorly
funded public health system has exacerbated the
spread of many diseases but particularly HIV
(Myer et al., 2004). For this reason most of the
study populations for HIV research in South
Africa are composed of black individuals from
poor socio-economic backgrounds and the grow-
ing volume of research should be underpinned by
assurance that it is not exploitative of a medically
and economically vulnerable group.
Ethical regulations give research participants
rights to autonomy, beneficence, non-malfeasance
and justice (World Medical Association, 2008).
Potential participants must also be given appro-
priate information about the study before agree-
ing to participate (Abdool Karim et al., 1998;
World Medical Association, 2008). Consent to
participate is only valid if it is ‘informed consent’.
Informed consent is a process by which the research
team and participant ensure that the participant is
competent to make decisions, has had the research
procedure explained, has understood the proce-
dure, and has come to a voluntary decision (Jefford
and Moore, 2008). Although informed consent is
always important, it is particularly crucial for
research involving vulnerable people, for example
those with both HIV and CHT.
Both HIV and CHT sufferers have been
described as vulnerable in research (Veatch, 1997;
Faden and Kass, 1998; Mugisha et al., 1998; Seedat
et al., 2004; Newman et al., 2006; Newman and
Kaloupek, 2009). However, the combined impact
of these two ‘insults’ on vulnerability has not been
explored. Several reasons for vulnerability in HIV
have been suggested (Abdool Karim et al., 1998;
Rankin et al., 2005) but how to address these
vulnerabilities to improve the consent process for
research involving participants with HIV remains
only partially explored. Similarly, it has been
suggested that people with CHT may also be
vulnerable in research because of the perceived
power differential between researcher and parti-
cipant (Yehuda, 2002; Newman and Kaloupek,
2009). Several studies have focused specifically on
the ethical aspects of recruiting participants for
research involving questions about traumatic
experiences (Yehuda, 2002; Seedat et al., 2004;
Newman and Kaloupek, 2009) and there is debate
over the potential harms and benefits for partici-
pants (Yehuda, 2002; Seedat et al., 2004; Newman
and Kaloupek, 2009). In this study we used qua-
litative methodology to provide insights into the
informed consent process for people with both
HIV and CHT.
Methods
Design, rationale and setting
This qualitative semi-structured interview study
investigated participants’ experiences of the consent
process for a cohort study titled ‘Neurocognitive
outcomes in HIV and childhood trauma’. This
cohort study aimed to identify neurocognitive
interactions between HIV infection and CHT in
women using: a clinician administered psychiatric
diagnostic interview; neurocognitive testing to
assess cognitive status; a blood test to provide a
CD4 count; and an functional magnetic resonance
imaging (fMRI) scan to facilitate an understanding
of functional brain changes that underlie cognitive
mechanisms in the context of these two conditions
(Spies et al., 2012).
To assess participants’ experiences of the con-
sent process a qualitative approach was adopted
to explore participants’ individual experiences of
an under-researched area (Sofaer, 1999). Indivi-
dual interviews were favoured over focus groups
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because of the sensitive nature of the study and
the difficulty of translating focus group tran-
scripts. The study was conducted at the Faculty of
Health Sciences, Tygerberg, South Africa.
Recruitment
Twenty five women, from Khayelitsha Town-
ship, were recruited immediately following their
final study appointment. The aims of the inter-
view were explained by a member of the study
team to avoid the interviewer’s presence influ-
encing participants’ decisions. Written consent
was obtained using one of two trained Xhosa
language interpreters.
Participants were all female, aged over 18 and
had no history of major head trauma. The only
additional criterion applied for the qualitative
study was immediate termination of the interview
if a participant became distressed. No participant
was excluded on this criterion.
Data collection
Face-to-face interviews, following a topic guide,
were conducted using an interpreter. The topic
guide included four main themes derived from a
literature review. It was piloted with a university
student in October 2011 (Appendix 1). The pilot
resulted in no major changes to the guide. Before
each interview, the age, ethnicity and place of
residence of the participant were recorded. All
interviews were digitally recorded and English
sections transcribed. One interpreter checked a
selection of transcripts while listening to the
recordings to identify any translation errors. None
were found.
Data analysis
Data collection and analysis occurred con-
currently. The interviewer transcribed all the
recordings before coding them following Ritchie
and Spencer 1994 Framework Analysis methodology
(Bryman and Burgess, 2007). As suggested by
Barbour (2001), coding of the initial five transcripts
was conducted independently by H.B. and H.L.
Coding was compared in detail and differences
were discussed extensively and agreement reached
over video-link. The remaining transcripts were
coded by H.B. with regular review and discussion
with H.L. Disconfirming evidence was sought
throughout.
All interview transcripts were entered into
NVivo9 to allow the analysis to be clearly docu-
mented at every stage of the process and to allow
future researchers to revisit the original data
and codes (Stake, 1995; Merriam, 1998). Charts
were constructed for each theme after the 18th
interview to ensure that any missed themes could
be explored in the final interviews. The charting
process was repeated after the final interviews.
The interviewer also kept a reflective diary
throughout the process as suggested by Watt
(2007), including interactions with team members
that influenced the ‘mapping and interpretation’
stage and allowed reflexivity (Glesne, 1999;
Russell and Kelly, 2002).
Results
A total of 25 face-to-face interviews lasting
17–40min took place between January and March
2012. All participants’ home language was Xhosa.
Data saturation was reached by interview 20.
Opinions on the cohort study were mostly positive.
Four themes were repeatedly raised: community
recruitment; incentives for participation; quality
of information provided; and misunderstandings
and unexpected events. Quotations have been
chosen on grounds of representativeness and
presented in boxes with participant identification
number and age.
Community recruitment
As a large number of participants meeting
specific criteria were required in a short space
of time, a large-scale community recruitment
method was utilised for the cohort study.
Recruiters contacted friends in the township and
organised meetings at clinics and with established
groups. In an area such as this, where many people
live openly with HIV, informal recruitment could
occur following the initial visits.
There was no evidence that this method caused
any coercion to consent and it was generally
regarded as a good method of informing large
groups about research. The recruiters appeared to
have a good understanding of the community’s
needs and to have presented the study in a clear
and appealing way. Women felt comfortable
being approached at both clinics and community
groups and most reported that their family and
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friends were supportive of their participation
although there was no sense that peer approval
was required for participation. The community’s
knowledge and acceptance of most people’s HIV
status made community recruitment easier for
this particular group. However, approximately a
quarter of women reported that an acquaintance
did not volunteer because they were unwilling to
disclose their status (see Box 1).
Incentives for participation
The women indicated that they believed that
there were both health and financial incentives
associated with participation.
Health incentives
The expectation of health incentives mostly
stemmed from the consent process. The women
discussed the lack of resources at their local
clinics; the majority preferring to visit the hospital
because of the better care they received. All
participants mentioned that a desire to under-
stand and improve their own health was a moti-
vating factor for their involvement. However, the
women’s responses indicate that information
provided during the consent process may have
inadvertently created false expectations of the
benefits of participation.
The fMRI scan was a clear incentive for most of
the women involved in the study. Women wanted
to ensure that their brains were functioning
normally and that they were ‘mentally stable’
(a translated term used to cover all descriptions
of good mental aptitude). Interest in the scan was
increased by knowledge of the impact HIV has
on cognitive functioning. Over half the women
expected to get results from the scan. However in
Box 1 A selection of quotations about community recruitment for the cohort study
Group
recruitment
I am also in a support group in Khayelitsha in one of the hospitals there whereby
HIV positive women are hanging together and supporting each other in the
group. And that is where I got informed and involved.
(P2 – 35 years)
I did talk to a few friends and family. As a result some of my friends are also
interested to come and see as they are also diagnosed with HIV.
(P15 – 32 years)
The reason I feel right in a group is because most of the time when you get told
something you get your own way of understanding certain things. And each
person has their own understanding. So when you go out of that place you can
advise each other and clarify to each other like this is what is happening. Rather
than being alone when you can miss some of the things, so it helps in a group
because the other people can tell you more. And maybe the other one who didn’t
attend then him and the other person telling him he can understand exactly what
you were told. (P21 – 32 years)
Stigma of being
involved
in HIV research
y I can tell the whole world I am HIV positive so to me it wasn’t what worried
me about how they told us in front of people but some of the people are still in
denial so they do not want people to know that they are HIV positive because
some of them they want to join the study, but they have been told the study is for
HIV positive so they go home and they didn’t join the study. (P7 – 48 years)
I was very free and relaxed the time the sisters spoke to us. The nurses weren’t
talking to me in person, I overheard the conversation and I got interested and
that is how I did. They gave me interest also the way they were telling us all these
things, even advising us where to go and what to do. (P15 – 32 years)
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reality, a woman would only be contacted in
follow-up if her scan showed an obvious struc-
tural abnormality accompanied by significantly
poor results in the neurocognitive assessment.
Furthermore, a minority of women erroneously
thought that the magnetic resonance imaging
would assess their whole body. The majority of
participants also indicated that they had expected
to learn about HIV and to get advice about
coping with the disease (see Box 2).
In contrast, the blood test was a significant
incentive for participants which met expecta-
tions. A blood sample was taken on the first
visit and the results were available at the final
visit. This allowed the women to obtain their
CD4 count. Women who did not have this
checked regularly were able to see how their
condition had progressed since diagnosis. Others
who had just started treatment could see if they
were benefitting from treatment before their
next clinic appointment. Even women who were
tested regularly felt reassured. In addition to
the blood test, the opportunity to talk about
their status and to be examined by the doctor
relieved stress as access to doctors was limited
locally (see Box 2).
Financial incentives
The women were given R100 (£8.33) for
transport and a R100 supermarket voucher at the
end of the study, a substantial gift for many of the
participants who were living in poverty. Financial
incentives were not routinely mentioned in the
information at consent for fear that they could
constitute undue influence to participate. The
majority of women appeared unaware of the
voucher but said that it would not have been an
incentive to participate. A minority felt that
advertisement of the vouchers would encourage
participation. However, most indicated that the
main incentive was to find out about their health
rather than to gain financially.
Despite the primary incentive being a desire to
know more about their health status, approxi-
mately a quarter of the women reported that the
financing of transport to the hospital was essential
and that receiving money after the first visit
excluded people who were unable to raise the
funds to attend that visit. Women suggested that
provision of transport would improve their study
experience (see Box 3).
Quality of information provided
The majority of women indicated that the
explanation of the cohort study was satisfactory.
Most had no questions, felt comfortable and
expressed positive opinions about the information
they were given. There was a good understanding
of confidentiality and the voluntary nature of the
research. However, over a third of participants
were also unsure about what would happen and
were surprised by some of the investigations.
Women reported that information provided at
recruitment in the community was verbal. The
majority were given a form to complete following
a talk from the recruiters to identify women who
had experienced CHT. Providing information
through meetings was generally regarded as suc-
cessful, however there were occasional reports of
a shortage of forms. Several women explained
that they were late for the meeting and missed
some of the information, resulting in anxiety at
Tygerberg. A minority of women reported that
the recruiters had been late for the meeting and
had insufficient time to explain the study fully.
Information provided during the consent pro-
cess at Tygerberg was also verbal. Participants
had the consent document explained to them and
then signed the form. The protocol instructed the
researchers to return the information parts of the
form to the participant while retaining the sig-
nature sheets. However, the first 18 interviewees
consistently reported that they were not given any
written information. Many women felt that written
information would have been helpful for personal
records and to share with others. The lack of written
information was brought to the attention of the
research team and rectified immediately. Conse-
quently, the final seven women interviewed all
received written information. Despite this, some
participants had not read it (see Box 4).
Misunderstandings and unexpected events
Despite the generally positive feedback about
the explanation given during the consent process,
there were three main areas of misunderstanding:
the use of in-depth trauma questions; the fMRI
process; and expectations of counselling.
Participants were frequently unaware that
they would be questioned about their CHT. For
the majority this was not a problem and they
commented that it was easy to discuss things
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pertaining to their own past lives. However, for
others, the questioning brought back memories
of traumatic events. For these individuals the
probing questions caused acute discomfort.
The erroneous expectations of the fMRI results
have been discussed in a previous section, but the
women also reported fear of the fMRI process.
The majority of participants commented on fear
Box 2 A selection of quotations about the perceived health incentives of the cohort study
Preference of
hospital care over
care in clinics
It is very tough in our community now when it comes to the health care in the
clinics, it is delayed so it takes so long and those people are too much lazy and
sometimes you can wake up early early in the morning to go to the clinic but
you have other priorities during the day and you could end up spending you
whole day in the clinicy Coming here I was so much impressed because
everything went to time here they would tell you that at this certain time you
will go here and at this time you will go to this place and after this place to this
place and everything is on timey (P8 – 32 years)
Actually in all the clinics on the locations, there is no hospitality for us as
patients compared with hospitals. I prefer the big hospitals, they show us so
much hospitality. (P16 – 34 years)
Incentive of the
fMRI scan
The scan that is what makes me part of the studyywhen I heard that there was
going to be a scan that’s what I wanted because a scan is so expensive going to a
private doctor so for me that is what I wanted. (P1 – 38 years)
For me to be crazy about this study it was about number one going to the scan
y People who are HIV positive when it comes to them getting sick some of
them get their meningitis and people think that they are crazy and some of the
effects are like oozing coming out of the ear but for me I just wanted to get on
the scan and get tested. (P2 – 35 years)
The most important thing that I saw was that there was a scanner process for you to
check how my mentality is and that I am mentally stable and that there is nothing
wrong with me and that everything is functioning in order. (P16 – 34 years)
The thing that made me want to be involved is that they are going to examine
the brain and I was not going to be charged for that. (P26 – 42 years)
The lady was told me saying you are going to the scan they will check
everything and they are going to tell us everything if there is anything that they
find. (P8 – 32 years)
Blood test
incentive
Now I heard about my CD4 count when I started ARVs last monthy when I
last tested was in November and it was 295 so it was low so I had to start the
ARVs and I started last month, this January, so now they took my blood and
my CD4 count has increased to 700 and something so by my clinic I would
only have known in six months time. Then they will take my blood in six
months time like I am just starting ARVs [Antiretroviral therapy] I do not
know if my CD4 count is increasing or decreasing then like now I know that it
did increase. (P3 – 34 years)
I wanted to know more about my own health, about my status and about my
CD4 count and if there is any illness within that. (P6–36 years)
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of the machine despite an explanation of what
would happen and an awareness of their rights to
withdraw at any point. However, when asked
what they would tell a future participant about
the process, the participants almost uniformly
gave very similar advice to that provided to them
before they entered the scanner.
Finally, over half of participants believed
that they were entering this study to learn about
HIV and to get advice about maintaining their
health. In particular about a third of participants
mentioned that they expected counselling about
medication adherence. Counselling and health
advice were not components of the cohort study.
The expectation of these components highlights a
misunderstanding of the information provided
during the consent process (see Box 5).
Discussion
This study is believed to be the first to address the
informed consent process for people with both
HIVand CHT. The consent process was largely well
Box 3 A selection of quotations about the perceived financial incentives
Money incentive I wanted them [friends she recruited from the community] to participate
because they are unemployed and at the same time there is that incentive
of the vouchery I would be part of it even if there was no incentive.
(P5 – 40 years)
Most people are coming for vouchers. Someone will hear from another
person who received something like this and then that person will
automatically want to come, just because she wants to get the same.
In my opinion, that is what will happen in most cases.
(P16 – 32 years)
I couldn’t care less about the voucher! I wanted to find out what is going on
with the HIV and the HIV patientsy There is not even a bit of me that
thinks people will come for the vouchers, especially the HIV patients,
because like they normally go to support groups which are away from their
location and they must take transport on their own. Most of the support
groups do not offer vouchers, so normally the HIV patients are just
interested in wanting to know their status and their whereabouts with HIV/
AIDS. (P15 – 26 years)
Money is essential
to facilitate
participation
Some of them, they want to come here but they didn’t have the money, the
cash, to came herey so money is only given on Wednesday [Study day] and
if you don’t have the money to come on Wednesday morning then you
cannot come. (P6 – 36 years)
There are also other people but they do not have means to come here, or
they do not have a way, a channel to come herey I can’t say really what is
the problem. According to the way I see it, it is transport because I did
experience suffering coming here in the morning yesterday. So the voucher I
got in here yesterday helped me a lot to come back here again. It gave me
more strength and eagerness to come. (P25 – 39 years)
Yes the people will love that [Provision of transport] because their only
problem to come and attend these things is that they don’t have money to go
to the places or for transport. People love the studies, with money or no
money. (P24 – 36 years)
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received. The aspects most frequently commented
upon were: community recruitment; incentives for
participation; quality of information provided; and
misunderstandings and unexpected events.
Comparison with previous research
The use of community recruitment for the
study was considered useful and women were
comfortable with both group recruitment and the
information delivered. There was no suggestion
that coercion was present. As anticipated by
Karwalajtys et al. (2010), recruiters being friends
with members of the community, speaking a
common language and having an awareness
of cultural norms, increased trust in the study.
Further exploration of the use of social networks
for recruitment, particularly focusing on possible
Box 4 A selection of quotations about the participants’ views on the quality of information provided
during the cohort study
Satisfaction with information
provided and confidentiality
Everything was clear to me, right, so I didn’t have any
questions. (P2 – 35 years)
I felt confident because it was confidential because when I had
to sign the form there was no one who had to look at the form
and I only gave it to the sister, so I was quite alright with the
whole signing of the form.
(P12 – 40 years)
All I can say is that I loved it. (P4 – 37 years)
Misunderstanding and anxiety Normally when I get called to the hospital I get worried sick and
I stress too much because like I know that I am a patient and I
know that everything that is coming from the hospital is about
me, so I just worry too much. But I didn’t expect anything or
some sort. I was called to the hospital so I was just worried, that
they would tell me something bad.
(P14 – 27 years)
The lady came, but it was very late, she couldn’t tell us really
about the study, but she requested that we give our phone
numbers and she insisted that she is going to phone us
according the study in Tygerbergy They didn’t tell me nothing
y I didn’t know what to do, I was just scared. (P17 – 34 years)
Written information I would love it [information about study] on written papers so
that I could keep it. (P18 – 43 years)
I would prefer to get the information on paper, in a more written
way so that I can read and understand.
(P14 – 27 years)
Yes there is a paper that she gave me, it is written in Xhosa, it is
by my house nowy Yes, yes it was useful. It is like the very
same things she asked me and the very same things that are
written in the paper it did make sense to me. (P24 – 36 years)
I am quite alright with it [Written information], I haven’t read it
yety I was fine with the verbal information I was relieved because
I got to connect with what she was saying. (P25 – 39 years)
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coercion to consent, is an area for further
research.
To provide consent, participants must be able
to understand, weigh-up and retain the informa-
tion given and then communicate their decisions
(Kylma et al., 1999; Jefford and Moore, 2008).
There is no evidence in the literature that
experience of CHT or HIV infection reduces
decisional capacity or susceptibility to coercion
(Faden and Kass, 1998; Newman et al., 2006;
Newman and Kaloupek, 2009). For these reasons
the consent process was not specifically tailored
for a group with both HIVand CHT. The acceptance
of a generic consent process by the population
supports this, indicating that future studies
involving this population need not be hindered by
a lack of specifically tailored consent procedures.
However, signposting the use of questions about
traumatic experiences in the consent process
should be considered, supporting previous find-
ings that reactions to these questions vary greatly
between individuals (Seedat et al., 2004; Newman
and Kaloupek, 2009).
Despite this overall acceptance, several parti-
cipants expected benefits from the study that
were beyond the true benefits, a situation of
Box 5 A selection of quotations about the misunderstandings and unexpected events encountered
by participants of the cohort study
Presence of unexpected questions
about childhood trauma
Maybe the other questions were unexpected so but it was
nothing personal like something I feel to share with someone.
So the questions were also fine. (P3 – 34 years)
I: So how did you feel when they started asking those
questions?
P: I was like for a moment shocked but I was alright, and I
answered back.
(P17 – 34 years)
Fear of the fMRI process I was the scared of the machine because I didn’t know what the
machine was about to do to mey I was scared because I
thought that they were going to put an injection on me. But then
they explained that the machine is not going to do nothing to
me just that I was to go in and listen to musicy They did
explain to me before everything and it did happen to me as I
was told. (P1 – 38 years)
The only time I was scared was when I went to the scan.
(P4 – 37 years)
It was terrible [the scan experience], I can’t breathe when they
put this thing over my face and head and they laid me down and
then they pushed me inside. I was afraid that I was going to die.
(P11 – 43 years)
Erroneous expectations of what
the study entailed
The sort of things I was expecting from this study was more like
counselling and stuff. I like to talk and be free and accept my
conditiony I expected that I would be empowered about my well
being and I expected to learn about how to take care of myself.
Things I must do and things I must not do, but mostly to be aware
as a patient how to live and to survive. (P14 – 27 years)
I was told that they are going to check from the head to the toes
as to if there is any illness in my body. (P4 – 37 years)
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therapeutic misconception (Appelbaum et al.,
2004). This common issue has been highlighted in
previous research with some suggesting that there
is a larger risk in research involving vulnerable
participants (Lee et al., 2001; Appelbaum et al.,
2004; Escobedo et al., 2007).
The main reason reported for participation was
gaining information about health. The women
received a CD4 count and were also examined by
a doctor for signs of major illness. Mental well-
being was assessed with a psychiatric diagnostic
interview and participants with a diagnosed
mental illness were referred to a psychiatric clinic
for further evaluation. However, participants
expected to receive HIV counselling, which was
not a component of the study. Moreover, the
majority of women believed the fMRI scan was
used to assess mental well-being with over half
expecting to receive results. The women felt that
any abnormality would be identified but an
in-depth investigation of participants’ brains was
never an aim of the study. The fMRI scans were
examined as a group to investigate any structural
factors that may underlie cognitive mechanisms
in HIV and CHT. The identification of a major
abnormality during research such as this is rare
because of the focus and expertise of the
researchers and the study aims (Mamourian,
2004; Hadskis et al., 2008).
These findings support a finding that ther-
apeutic misconception is common in paediatric
neuroimaging research (Hadskis et al., 2008).
Moreover, they reinforce empirical evidence
showing that people with poorer health and are at
a greater risk of therapeutic misconception
(Appelbaum et al., 2004). Therapeutic mis-
conception has also been identified as a possible
complication of research in Sub-Saharan Africa
because of recent advances in health care and the
accompanying increased research activity com-
bined with the high social status of researchers in
communities with a low standard of education
(Fitzgerald et al., 2002; Yousuf et al., 2007;
Ogwuegbu and Eze, 2009; Halverson and Ross,
2012). This may have been a contributing factor in
this study.
Secondary to this, participants in research
often want to believe that participation leads to
additional benefits (Lema, 2009). This has been
demonstrated in early phase trials for novel cancer
therapies (Jansen, 2011) and may also impact
people suffering from chronic infections such as
HIV. Thus in this study the therapeutic mis-
conception identified may have been a bidirec-
tional problem of a lack of pertinent information
in the consent process and participants wanting
someone to be helping them, as suggested by
Lema (2009). This ‘therapeutic optimism’ – a
hope of identification of a cure through the study
investigations despite a high improbability – can
exist even using the optimum consent procedure
(Horng and Grady, 2003). Complete elimination
of therapeutic optimism may be an ethical ideal
which is impossible to meet. However, provision
of clearer information at consent about the true
benefits, and fuller explanation of the aims of
investigations could lessen the risk of therapeutic
misconception in future studies.
Participants’ understanding of the study may
also have been compromised by the lack of
written information during the first 18 interviews.
The misunderstandings may indicate that the
provision of retainable information would
have been beneficial. The use of audio-recorded
information at consent has improved patients’
understanding in previous research (Lloyd et al.,
2008). Given that half of the participants who
received written information reported having not
read it, or preferred the verbal explanation, this
method could be considered for future studies.
Limitations
This was a small study involving 25 short
interviews in one location. Our findings are site
specific, and caution should be exercised in
making generalisations to other locations. How-
ever, in relation to validity, care was taken in the
initial analysis to ensure the development and
consistent use of a coding framework grounded in
the data that was available. The parent study,
and consequently this study, drew its participants
from an area of severe deprivation and from
a community very open about HIV status. Such
acceptance may not be generalisable to other
township communities in South Africa. A further
limitation was one of language: the use of
interpreters added a risk of data being lost or
misconstrued despite attempts to mitigate this.
As translated interviews were used as data, some
ethnically relevant terms may not have been
conveyed effectively by English equivalents.
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Use of interpreters also prevented the use of focus
groups which could have provided triangulation of
data as well as allowing participants to interact with
each other. Triangulation through other methods
was not possible due to time constraints.
Despite these limitations, this study had a tan-
gible impact on the parent study. Future studies
could minimise these limitations by deploying
bilingual interviewers to avoid the issues of
translation; including a larger and/or broader
sample size and including methods to provide
triangulation of data.
Summary
This study is believed to be the first on the con-
sent process for people with both HIV and CHT.
As such, it provides a useful baseline for future
research. It highlights, in particular, the risks of
therapeutic misconception unless special care is
taken during the consent process.
Despite its size this study had a measurable
impact on the ‘Neurocognitive outcomes in
HIV and childhood trauma’ cohort study. It has
supported previous research indicating that a
generic consent process is appropriate for parti-
cipants with both HIV and CHT. However,
this study has also highlighted the importance of
full explanation of the benefits to participants of
any investigations carried out during the research
and emphasises the importance of providing
retainable information during the consent pro-
cess. Above all, participants appreciated the
opportunity to be involved in research and were
mostly content with the consent process for this
cohort study.
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Appendix 1
This topic guide is to be used in a study to
ascertain the views of women with HIV and
childhood trauma in South Africa on the consent
process for a research project. The semi-
structured interviews followed this guide. The
interviews did not necessarily use this exact
wording but each included discussion of all the
topic headings.
Opinions on the consent procedure
1. Could you describe in your own words how
you became involved in the research?
For this question the aim is to discover: why
participants were willing to get involved; if
they spoke to anyone about the project and
how they felt after agreeing to be involved.
The following prompts may be used to probe
answers further:
J Why were you willing to get involved?
J Who did you talk to about participating in
this research project?
J When you signed the form how did you feel?
Information provided
2. What information were you given about the
study?
For this question the aim is to discover: how
easy the information was to understand; if any
questions were asked about the process and
how participants felt about questioning the
researchers if they did. Also to try and determine
if participants became concerned during the study
and if so, how this was resolved. The following
prompts may be used to probe answers further
J Was the information easy to read?
J Was the information easy to understand?
J Did you get an opportunity to ask questions?
J How did you feel about asking the research-
ers questions?
J Did any questions or concerns emerge
during the research?
J How did you deal with these concerns?
J Did you feel able to pull out of the research?
J Was it clear that you could withdraw at
anytime?
Surprises
3. Was any part of the research project not what
you expected it to be?
This question aims to determine how partici-
pants felt about the research; if anything
happened that they were not expecting and
how they felt during the investigations. The
following prompts may be used to probe answers
J On the morning of each of you appoint-
ments, can you tell me how you felt?
J Were any of the investigations done as part
of the research not how you expected?
J How did you find the MRI scan?
J How did the questionnaires make you feel?
Improvements
4. If you were to change the consent procedure for
this study, is there anything you would have
done differently?
This question seeks to identify if any changes
could be made to the process of consent to make
it better. This could involve changing the length
of appointments, altering the explanation or
making the information more accessible. The
following probing questions may be used
J Could the length of any of the appointments
been changed?
J Would you alter the explanation of the
study?
J Could the information given about the study
be made more accessible?
Conclusion
5. Is there anything else you would like to tell me?
All the answers you have provided will be
completely anonymous and stored securely.
Thank you for giving up your time to help with
this research.
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